noscript

QBiotics Group

Australia|Pharmaceuticals

QBiotics Investor Overview : Game-Changing Pharmaceuticals

Cancer is responsible for one in six deaths, making it the second most common cause of death globally.  

Surgery, radiotherapy, chemotherapy and immunotherapies for cancer have varying degrees of success, side effects and recovery; and they are often very expensive. 

There is a compelling need for a non-invasive treatment which targets and kills only the tumour, and ideally any secondary tumours, with minimal/no systemic side effects; at a lower cost.

QBiotics’ outstanding advantages :

The game-changing anti-cancer compound, tigilanol tiglate, injected directly into solid tumours is disrupting the treatment of various cancers. Its unique mode of action completely destroys the tumour and promotes rapid and complete healing of the site, often after one injection. It has been launched for Veterinary use in the USA, Europe (27 countries) and Australia). Numerous clinical trials are in progress for various cancers in humans.

A unique wound healing agent, EBC-1013, has a novel mode of action combining antimicrobial activity, biofilm disruption and immune system stimulation for both human and veterinary use. Chronic wounds impact tens of millions of people globally and cost billions of dollars pa.

The simultaneous human/veterinary development model delivers earlier, greater returns. 

Proprietary drug discovery technology EcoLogic™ identifies next-generation antibiotics and anti-inflammatories, expanding the product portfolio and providing future growth opportunities. 

World-class Board and Leadership Team to take the company public and to becoming one of Australia’s foremost healthcare successes. They have a proven track record of growing and listing global companies which have very significant market capitalisations.

Predicted to be 'one of the country’s healthcare success stories; in the same vein as CSL, Cochlear and ResMed.' 

$85m raised in 2021 provides a 3-year runway to achieve key milestones.  

Clear exit strategy through an IPO and listing on the stock exchange.  

The only way to acquire QBiotics shares is through private, off-market share sales. 

Parcels of shares are available for purchase through Achieve Capital Pty Limited. Min. purchase is $5,000 worth of shares. Contact [email protected]

Background & History

Cras eleifend purus vitae mattis imperdiet.



Integer fringilla mi ut sem tincidunt, in sagittis odio mollis. Suspendisse a diam lectus. Cras at suscipit risus.

Fusce gravida, ante quis mattis ultricies, lorem neque suscipit ex, semper tincidunt dui mi sit amet elit.



Fusce scelerisque massa sit amet turpis rutrum semper.

Donec ac orci aliquet, tincidunt ligula eu, finibus libero. Pellentesque pharetra consequat congue. Pellentesque quis dolor augue.



Proin non ipsum vel risus rutrum porta. Vivamus sem enim, interdum pretium metus eu, ornare posuere nisl. Duis venenatis accumsan enim, quis blandit lacus posuere at. Sed tincidunt congue blandit. Maecenas interdum quam in mauris condimentum luctus. Donec fermentum egestas risus vel cursus. Ut metus justo, rutrum vel sem ut, consequat laoreet ante. Nunc tincidunt viverra metus, tincidunt viverra elit iaculis sit amet. Integer ullamcorper hendrerit eleifend. Curabitur massa nisi, tempus eget fermentum quis, volutpat non sem. Integer id sagittis dolor. Donec nunc erat, maximus sed magna id, faucibus ultricies velit. Nunc lobortis eget urna at semper.



Donec sollicitudin, tortor ac interdum tempus, mi odio fringilla lacus, sit amet hendrerit mi purus vel nisi. Phasellus nulla ligula, congue quis ullamcorper eget, egestas id leo. Sed et rhoncus libero. Mauris tincidunt ultricies justo ut tincidunt. Nam rhoncus est non erat auctor mattis. Sed quis consectetur ma


Open an account to get
access to more details

Key Achievement & Milestones

Cras eleifend purus vitae mattis imperdiet.



Integer fringilla mi ut sem tincidunt, in sagittis odio mollis. Suspendisse a diam lectus. Cras at suscipit risus.

Fusce gravida, ante quis mattis ultricies, lorem neque suscipit ex, semper tincidunt dui mi sit amet elit.



Fusce scelerisque massa sit amet turpis rutrum semper.

Donec ac orci aliquet, tincidunt ligula eu, finibus libero. Pellentesque pharetra consequat congue. Pellentesque quis dolor augue.



Proin non ipsum vel risus rutrum porta. Vivamus sem enim, interdum pretium metus eu, ornare posuere nisl. Duis venenatis accumsan enim, quis blandit lacus posuere at. Sed tincidunt congue blandit. Maecenas interdum quam in mauris condimentum luctus. Donec fermentum egestas risus vel cursus. Ut metus justo, rutrum vel sem ut, consequat laoreet ante. Nunc tincidunt viverra metus, tincidunt viverra elit iaculis sit amet. Integer ullamcorper hendrerit eleifend. Curabitur massa nisi, tempus eget fermentum quis, volutpat non sem. Integer id sagittis dolor. Donec nunc erat, maximus sed magna id, faucibus ultricies velit. Nunc lobortis eget urna at semper.



Donec sollicitudin, tortor ac interdum tempus, mi odio fringilla lacus, sit amet hendrerit mi purus vel nisi. Phasellus nulla ligula, congue quis ullamcorper eget, egestas id leo. Sed et rhoncus libero. Mauris tincidunt ultricies justo ut tincidunt. Nam rhoncus est non erat auctor mattis. Sed quis consectetur ma


Open an account to get
access to more details

Board & Management

Cras eleifend purus vitae mattis imperdiet.



Integer fringilla mi ut sem tincidunt, in sagittis odio mollis. Suspendisse a diam lectus. Cras at suscipit risus.

Fusce gravida, ante quis mattis ultricies, lorem neque suscipit ex, semper tincidunt dui mi sit amet elit.



Fusce scelerisque massa sit amet turpis rutrum semper.

Donec ac orci aliquet, tincidunt ligula eu, finibus libero. Pellentesque pharetra consequat congue. Pellentesque quis dolor augue.



Proin non ipsum vel risus rutrum porta. Vivamus sem enim, interdum pretium metus eu, ornare posuere nisl. Duis venenatis accumsan enim, quis blandit lacus posuere at. Sed tincidunt congue blandit. Maecenas interdum quam in mauris condimentum luctus. Donec fermentum egestas risus vel cursus. Ut metus justo, rutrum vel sem ut, consequat laoreet ante. Nunc tincidunt viverra metus, tincidunt viverra elit iaculis sit amet. Integer ullamcorper hendrerit eleifend. Curabitur massa nisi, tempus eget fermentum quis, volutpat non sem. Integer id sagittis dolor. Donec nunc erat, maximus sed magna id, faucibus ultricies velit. Nunc lobortis eget urna at semper.



Donec sollicitudin, tortor ac interdum tempus, mi odio fringilla lacus, sit amet hendrerit mi purus vel nisi. Phasellus nulla ligula, congue quis ullamcorper eget, egestas id leo. Sed et rhoncus libero. Mauris tincidunt ultricies justo ut tincidunt. Nam rhoncus est non erat


Open an account to get
access to more details

Investment Highlights

Ut dignissim eget felis non ultrices. Vivamus fermentum erat at velit varius molestie.

Duis vitae mi neque.



Donec tincidunt, dolor luctus lobortis ultrices, turpis eros cursus turpis, maximus tempor lectus lectus vel diam.



Proin neque lacus, semper vel ex at, eleifend rhoncus est.

Cras non nisi urna. Sed feugiat dignissim erat, eget convallis nisl blandit a. Nullam fringilla diam eget dui placerat fermentum. Maecenas malesuada viverra leo eu bibendum. Nam vulputate enim velit, eu pretium justo tristique ac.



Nam vitae varius augue. Nam pharetra facilisis elementum. Sed nisl risus, vestibulum ut velit at, dapibus sagittis arcu. Nullam sed dolor suscipit, efficitur enim quis, vestibulum sapien. Nunc convallis mauris nec nibh mollis, eget aliquet odio tincidunt.

Phasellus faucibus sem mauris, sed iaculis nisl egestas sed. Sed sit amet gravida elit, sagittis sollicitudin nulla. Vivamus auctor arcu eu scelerisque convallis. Phasellus scelerisque ultrices tincidunt. Curabitur odio libero, faucibus et felis nec, pulvinar facilisis urna. Interdum et malesuada fames ac ante ipsum primis in faucibus. Maecenas ultrices in velit at ultrices.



Pellentesque tempor a risus in elementum. Proin malesuada mauris et mauris bibendum laoreet. Vivamus maximus nulla volutpat, ornare lorem a, vulputate enim.

In dui nisl, vestibulum eu finibus pretium, eleifend et eros. Vivamus in venenatis risus, ut dictum vel


Open an account to get
access to more details

See more exciting opportunities on CRIISP

Melbourne Victory FC

Melbourne Victory Football Club is an Australian professional soccer club based in Melbourne, Victoria. Competing in the country's premier competition, the A-League, under licence from Football Australia, Victory entered the competition in the inaugural season as the only Victorian-based club in...

flag_australia
Australia AUD
Sport Secondary Sales

Paycepaid

Paycepaid is a Software as a Service debt collection solution unlike any on the market today with a heavy focus on the debtor. Empowering businesses to manage their end to end collections while providing debtors with a magnitude of options to reduce financial stress and anxiety.

flag_australia
Australia AUD
Online Marketplace Seed Round

Mint Payments Limited

Mint Payments is an innovative payments solution provider focussed on offering full-service, end-to-end payment solutions for all businesses looking to accept payments from their customers and make payments to their suppliers.

flag_australia
Australia AUD
Payment Services Secondary Sales

Wholesale Investor

Wholesale Investor is a private investment platform across Australia, Singapore, and the UK with a 14-year track record of connecting growth companies and HNW investors. Our subscribers have benefited from gaining early access to private opportunities, including startups, scale-ups, small caps,...

flag_australia
Australia AUD
Fintech Series B+

eleXsys Energy (Parent Company of Planet Ark Power)

eleXsys Energy transforms the economics of optimised commercial rooftop solar and battery installations by developing grid-connected microgrid solutions that overcome industry voltage regulation and the restrictions that curtail the export of surplus clean energy into adjacent low voltage networks.

flag_australia
Australia AUD
Renewable Energy Pre-IPO

PRIMAL ORGANIX

Primal Organix has created the world’s first botanically derived Terpene blended anti-anxiety health supplement that manages anxiety in minutes. Our purpose is to support positive mental ill-health and well-being in all human beings.

flag_australia
Australia AUD
Healthcare Series A

Surf Lakes Holdings (Secondary Market Transaction)

Surf Lakes established in 2016, is an unlisted public company which provides a technologically advanced wave-generating device and bathymetric reef designs to theme, amusement and water sports parks operators. The Company in its short time of operations has been able to set its footprints...

flag_australia
Australia AUD
Sportech Pre-IPO

Pacific Channel

Pacific Channel is a deep-tech VC fund with offices in Auckland and San Diego. It currently has >$80 million of funds under management through Pacific Channel Funds I, II and SPVs, in which our management are the largest private investors and our sovereign is the largest institutional investor.

flag_new zealand
New Zealand NZD
Biotechnology Fund

EBR Systems (ASX: EBR)

EBR Systems is driven to deliver superior treatment for millions of patients suffering from cardiac rhythm diseases by developing safe, clinically superior, cost-effective and reliable therapies using wireless cardiac stimulation.

flag_australia
Australia AUD
Healthtech Listed

Join over 32,300+ sophisticated investors

Join Now